Skip to main content
Camilla Graham, MD, Infectious Disease, Boston, MA

CamillaSGrahamMD

Infectious Disease Boston, MA

Assistant Clinical Professor, Medicine, Beth Israel Deaconess Medical Center

Dr. Graham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Graham's full profile

Already have an account?

  • Office

    330 Brookline Ave
    # Beth
    Boston, MA 02215
    Phone+1 617-632-7706

Education & Training

  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1998 - 2001
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1994 - 1997
  • MCP-Hahnemann College of Medicine
    MCP-Hahnemann College of MedicineClass of 1994

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1996 - 2025
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

Press Mentions

  • PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis and Use of a Bayesian Statistical Analysis for LYT-100 at CHEST 2024 Annual Meeting
    PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis and Use of a Bayesian Statistical Analysis for LYT-100 at CHEST 2024 Annual MeetingOctober 10th, 2024
  • PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting
    PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual MeetingOctober 9th, 2024
  • Task Force Recommends Hepatitis B Screening for People at Increased Risk
    Task Force Recommends Hepatitis B Screening for People at Increased RiskFebruary 5th, 2021
  • Join now to see all

Grant Support

  • Cellular Immunity To Hepatitis C Virus In HIVNational Institute On Drug Abuse2001–2005